Q/C Technologies, Inc. Fair Value Adjustment of Warrants
Q/C Technologies, Inc. (QCLS) reported Fair Value Adjustment of Warrants of $4.41 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-04-15
- Q/C Technologies, Inc. fair value adjustment of warrants for the quarter ending 2024-12-31 was $0.00.
- Q/C Technologies, Inc. fair value adjustment of warrants for the quarter ending 2024-09-30 was $17.00K.
- Q/C Technologies, Inc. fair value adjustment of warrants for the quarter ending 2024-06-30 was -$2.70M.
- Q/C Technologies, Inc. fair value adjustment of warrants for the quarter ending 2024-03-31 was $7.09M.
- Q/C Technologies, Inc. fair value adjustment of warrants for fiscal 2024 was $4.41M.
- Q/C Technologies, Inc. fair value adjustment of warrants for fiscal 2023 was -$9.76M.
| Period end | Fair Value Adjustment of Warrants 0 month | Fair Value Adjustment of Warrants 0 month as first filed | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $17.00K derived: sum of 2 quarters · filed 2026-04-15 | -$2.68M derived: sum of 3 quarters · filed 2026-04-15 | $4.41M 10-K · filed 2026-04-15 | ||
| 2024-09-30 | $17.00K 10-Q · filed 2025-11-19 | -$2.68M derived: sum of 2 quarters · filed 2025-11-19 | $4.41M 10-Q · filed 2025-11-19 | $2.82M derived: sum of 4 quarters · filed 2025-11-19 | ||
| 2024-06-30 | -$2.70M 10-Q · filed 2025-08-19 | $4.39M 10-Q · filed 2025-08-19 | $2.80M derived: sum of 3 quarters · filed 2025-08-19 | -$2.55M derived: sum of 4 quarters · filed 2025-08-19 | ||
| 2024-03-31 | $7.09M 10-Q · filed 2025-05-15 | $5.50M derived: sum of 2 quarters · filed 2025-05-15 | $148.00K derived: sum of 3 quarters · filed 2025-05-15 | -$2.78M derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | -$1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-11 | -$6.95M derived: sum of 2 quarters · filed 2025-04-11 | -$9.88M derived: sum of 3 quarters · filed 2025-04-11 | -$9.76M 10-K · filed 2025-04-11 | ||
| 2023-09-30 | -$5.36M 10-Q · filed 2024-11-14 | -$8.29M derived: sum of 2 quarters · filed 2024-11-14 | -$8.17M 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | -$2.93M 10-Q · filed 2024-08-19 | -$2.81M 10-Q · filed 2024-08-19 | ||||
| 2023-03-31 | -$1.18M 10-Q · filed 2024-05-15 | |||||
| 2022-07-07 | $84.85K 10-K · filed 2024-04-01 | $93.23K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |